companydata.dkCONTERA PHARMA A/S: Financial statements 2017
CVR: 33062214
CONTERA PHARMA A/S (CVR 33062214) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,418,538 and a net result of DKK -418,534 compared with DKK 866,364 the year before. That is a decrease of 54.4% compared with the year before. Equity amounted to DKK 1,048,360. The solvency ratio was 73.7%. The company had 2 employees in the financial year.
- Gross Profit
- 1,418,538 kr.
- Profit/Loss
- -418,534 kr.
- Equity
- 1,048,360 kr.
- Total Assets
- 1,422,930 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.4 mio. | -419 t. | 1 mio. | 2 |
| 2016 | - | 3.1 mio. | 866 t. | 1.5 mio. | - |
| 2015 | - | 445 t. | -1.1 mio. | 601 t. | - |
| 2014 | - | -126 t. | -3.2 mio. | 1.7 mio. | - |
| 2013 | - | -3.4 mio. | -4.7 mio. | 1.7 mio. | - |
Find more companies like CONTERA PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
CONTERA PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 3,107,817, and the net result was DKK 866,364.
About CONTERA PHARMA A/S
CONTERA PHARMA A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CONTERA PHARMA ApS and CONCIT PHARMA ApS. The management consists of Thomas Nikolaj Sager. The company is owned by Bukwang Pharmaceutical Co., Ltd. The company has 1 employee. In 2025, the company reported a gross profit of DKK 20,632,306 and a net result of DKK -4,783,781 compared with DKK -69,213,744 the year before. Equity amounted to DKK 79,471,802.